Pirfenidone attenuates homocysteine-induced apoptosis by regulating the connexin 43 pathway in H9C2 cells

Pirfenidone (PFD) is an anti-fibrotic agent that is clinically used in the treatment of idiopathic pulmonary fibrosis. PFD has been shown to exert protective effects against damage to orbital fibroblasts, endothelial cells, liver cells and renal proximal tubular cells; however, its effect on myocard...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kai, Chen, Ling, Ouyang, Yuanshuo, Zhang, Liang, Li, Xinzhi, Li, Li, Si, Junqiang, Wang, Li, Ma, Ketao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053877/
https://www.ncbi.nlm.nih.gov/pubmed/32124965
http://dx.doi.org/10.3892/ijmm.2020.4497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053877/
https://www.ncbi.nlm.nih.gov/pubmed/32124965
http://dx.doi.org/10.3892/ijmm.2020.4497

Ejemplares similares